Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Data Do Not Support Ban on Silicone Breast Implants
Sally Satel, MD, USA Today, 4-11-05

Satel notes that feminist groups, long the self-proclaimed guardians of “choice” for women, have turned their back on choice and science in their stand against silicone breast implants.

Ever since women began enlarging their breasts with implants, feminists have been upset. So, predictably, when a Food and Drug Administration advisory panel begins hearings today to consider approval of silicone-gel-filled breast implants, feminist health activists will urge them to reject the devices as unsafe. But the data emphatically do not justify their concern. Unfortunately, women can't depend on such groups as the National Organization for Women to give them the facts.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000